Market Performance of Mbody Ai (MBAI)
- Closing Price (05:15 AM Central Europe, Wednesday 21): USD 2.37
- 24‑hour Change: –18 %
- Last 24‑hour Turnover: USD 97.9 k
- Shares Outstanding: 15.3 million
- Market Capitalisation: USD 33.8 million
- Simple Moving Average (200 days): USD 9.62
- 52‑Week High: USD 27.44 (26 January 2026)
- 52‑Week Low: USD 2.21 (19 October 2026)
- Month‑to‑Date Performance (since month‑end): –63.69 %
24‑Hour Performance of Peer Companies
| Ticker | 24‑Hour Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| NNOX (Nano‑x Imaging) | –9.49 % | USD 0.41 | USD 31.7 million | – |
| SAE.TA (Shufersal) | –0.05 % | ILA 3,679 | ILA 3.2 billion | 14.8 |
| PLRZ (Polyrizon) | –3.15 % | USD 9.15 | USD 24.3 million | – |
| SKBN.TA (Shikun & Binui) | –0.88 % | ILA 1,862 | ILA 3.4 billion | 188.83 |
| ZMDTF (Zoomd) | 0 % | USD 0.26 | USD 26.3 million | 6.38 |
Company Profile – Check Cap Ltd.
Check Cap Ltd. is a health‑care equipment and supply company headquartered in Isfiya, Israel. The company develops and manufactures medical diagnostic equipment, focusing on a non‑invasive device for detecting rectal polyps. The system uses a tiny, sonar‑like capsule that ingests and transmits data to a wrist‑worn accessory, producing a three‑dimensional reconstructed image of the colon. The company’s website is www.check-cap.com . Check Cap’s shares are traded on the Nasdaq exchange and the company went public on 19 February 2015.
